Click image to enlarge
The obvious 2004 to 2005 marginal trends reversal of Total Annual Net Costs for SSRI / SNRI Prescriptions correlates with: -
1 The “Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitors (SSRIs)” published December 2004
2 The "House of Commons, Health Committee’s examination into The Influence of the Pharmaceutical Industry" - initiated June 2004 - report published April 5th 2005
Data collection reference:
Department of Health; NHS; Prescription Cost Analysis (PCA) - England.
1998 to 2007:
10–C-04 1 Tuesday